Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the PEG ratio high or low?
The PEG ratio of 0.98 is in line with its 1-year average of 1.06, around the middle of its 1-year range (0.80–1.36).
As of 2026-10-06T14:56:25.244Z.
Calculation as of: 2026-10-06T14:56:25.244Z.
Quote observation: 2026-10-06T14:55:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 06562fb702a0da71b906a258253127b31d640f45e795332ac5785183133d8a11
PEG RATIO
0.98
PEG RATIO AVG TTM
N/A
PEG RATIO AVG 3Y
N/A
PEG RATIO AVG 5Y
N/A
PEG RATIO AVG 10Y
N/A
PEG RATIO AVG 15Y
N/A
PEG RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.83
median of 58 covered companies
CURRENT VS SECTOR MEDIAN
-46.59%
vs the sector median at left
Collegium Pharmaceutical, Inc.
Market Cap
$708.19M
PEG Ratio
0.98
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Collegium Pharmaceutical, Inc. (COLL) | $708.19M | 0.98 |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $707.95M | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $704.02M | N/A |
| Cytek Biosciences, Inc. (CTKB)vs › | $716.10M | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $718.57M | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $692.29M | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $731.45M | N/A |
| Annexon, Inc. (ANNX)vs › | $679.13M | N/A |
| Helus Pharma Inc. (HELP)vs › | $666.95M | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $666.36M | N/A |
PEG Ratio
0.98
P/E Ratio
17.6
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2026-10-05 | 0.99 |
| 2026-10-02 | 0.99 |
| 2026-10-01 | 0.99 |
| 2026-09-30 | 0.98 |
| 2026-09-29 | 1.00 |
| 2026-09-28 | 1.02 |
| 2026-09-25 | 1.02 |
| 2026-09-24 | 1.02 |
| 2026-09-23 | 1.01 |
| 2026-09-22 | 1.03 |
| 2026-09-21 | 1.04 |
| 2026-09-18 | 1.03 |
| 2026-09-17 | 1.01 |
| 2026-09-16 | 1.00 |
| 2026-09-15 | 0.99 |
| 2026-09-14 | 1.03 |
| 2026-09-11 | 1.03 |
| 2026-09-10 | 1.03 |
| 2026-09-09 | 1.05 |
| 2026-09-08 | 1.05 |
| 2026-09-04 | 1.06 |
| 2026-09-03 | 1.07 |
| 2026-09-02 | 1.10 |
| 2026-09-01 | 1.08 |
| 2026-08-31 | 1.11 |
| 2026-08-28 | 1.14 |
| 2026-08-27 | 1.19 |
| 2026-08-26 | 1.24 |
| 2026-08-25 | 1.24 |
| 2026-08-24 | 1.23 |
| 2026-08-21 | 1.22 |
| 2026-08-20 | 1.24 |
| 2026-08-19 | 1.30 |
| 2026-08-18 | 1.29 |
| 2026-08-17 | 1.27 |
| 2026-08-14 | 1.27 |
| 2026-08-13 | 1.27 |
| 2026-08-12 | 1.16 |
| 2026-08-11 | 1.17 |
| 2026-08-10 | 1.23 |
| 2026-08-07 | 1.33 |
| 2026-08-06 | 0.80 |
| 2026-08-05 | 0.98 |
| 2026-08-04 | 0.98 |
| 2026-08-03 | 0.98 |
| 2026-07-31 | 0.97 |
| 2026-07-30 | 0.99 |
| 2026-07-29 | 0.99 |
| 2026-07-28 | 0.98 |
| 2026-07-27 | 0.97 |
| 2026-07-24 | 0.97 |
| 2026-07-23 | 0.98 |
| 2026-07-22 | 0.95 |
| 2026-07-21 | 0.98 |
| 2026-07-20 | 0.97 |
| 2026-07-17 | 0.99 |
| 2026-07-16 | 0.99 |
| 2026-07-15 | 1.01 |
| 2026-07-14 | 0.96 |
| 2026-07-13 | 0.95 |
| 2026-07-10 | 0.97 |
| 2026-07-09 | 0.98 |
| 2026-07-08 | 0.98 |
| 2026-07-07 | 1.00 |
| 2026-07-06 | 1.03 |
| 2026-07-02 | 1.02 |
| 2026-07-01 | 0.98 |
| 2026-06-30 | 0.99 |
| 2026-06-29 | 0.99 |
| 2026-06-26 | 1.00 |
| 2026-06-25 | 0.96 |
| 2026-06-24 | 0.98 |
| 2026-06-23 | 0.95 |
| 2026-06-22 | 0.92 |
| 2026-06-18 | 0.92 |
| 2026-06-17 | 0.92 |
| 2026-06-16 | 0.95 |
| 2026-06-15 | 0.94 |
| 2026-06-12 | 0.95 |
| 2026-06-11 | 0.94 |
| 2026-06-10 | 0.95 |
| 2026-06-09 | 0.94 |
| 2026-06-08 | 0.91 |
| 2026-06-05 | 0.92 |
| 2026-06-04 | 0.90 |
| 2026-06-03 | 0.85 |
| 2026-06-02 | 0.84 |
| 2026-06-01 | 0.87 |
| 2026-05-29 | 0.92 |
| 2026-05-28 | 0.91 |
| 2026-05-27 | 0.92 |
| 2026-05-26 | 0.93 |
| 2026-05-22 | 0.93 |
| 2026-05-21 | 0.94 |
| 2026-05-20 | 0.94 |
| 2026-05-19 | 0.92 |
| 2026-05-18 | 0.92 |
| 2026-05-15 | 0.93 |
| 2026-05-14 | 0.95 |
| 2026-05-13 | 0.96 |
| 2026-05-12 | 0.98 |
| 2026-05-11 | 0.98 |
| 2026-05-08 | 1.04 |
| 2026-05-07 | 1.28 |
| 2026-05-06 | 1.19 |
| 2026-05-05 | 1.15 |
| 2026-05-04 | 1.13 |
| 2026-05-01 | 1.12 |
| 2026-04-30 | 1.10 |
| 2026-04-29 | 1.10 |
| 2026-04-28 | 1.07 |
| 2026-04-27 | 1.07 |
| 2026-04-24 | 1.06 |
| 2026-04-23 | 1.05 |
| 2026-04-22 | 1.08 |
| 2026-04-21 | 1.09 |
| 2026-04-20 | 1.12 |
| 2026-04-17 | 1.12 |
| 2026-04-16 | 1.08 |
| 2026-04-15 | 1.14 |
| 2026-04-14 | 1.16 |
| 2026-04-13 | 1.16 |
| 2026-04-10 | 1.16 |
| 2026-04-09 | 1.15 |
| 2026-04-08 | 1.09 |
| 2026-04-07 | 1.07 |
| 2026-04-06 | 1.06 |
| 2026-04-02 | 1.05 |
| 2026-04-01 | 1.09 |
| 2026-03-31 | 1.08 |
| 2026-03-30 | 1.04 |
| 2026-03-27 | 1.06 |
| 2026-03-26 | 1.09 |
| 2026-03-25 | 1.09 |
| 2026-03-24 | 1.08 |
| 2026-03-23 | 1.13 |
| 2026-03-20 | 1.16 |
| 2026-03-19 | 1.18 |
| 2026-03-18 | 1.14 |
| 2026-03-17 | 1.17 |
| 2026-03-16 | 1.16 |
| 2026-03-13 | 1.13 |
| 2026-03-12 | 1.14 |
| 2026-03-11 | 1.16 |
| 2026-03-10 | 1.19 |
| 2026-03-09 | 1.22 |
| 2026-03-06 | 1.22 |
| 2026-03-05 | 1.22 |
| 2026-03-04 | 1.29 |
| 2026-03-03 | 1.31 |
| 2026-03-02 | 1.36 |
| 2026-02-27 | 1.36 |